We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
World Heart Corp - WHRT and TSE/WHT
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
500 15 0 WHRT
Emcee:  Dan Hamilton Type:  Unmoderated
World Heart Corp is traded on the Nasdaq National Market (WHRT), and the
Toronto Stock Exchange (WHT). The web site is World Heart has commenced "in vivo" testing
of its HeartSaver Ventricular Assist Device (VAD). A VAD is an
artificial heart which can, without replacing the heart, either assist
or assume the heart's natural pumping function.

The current estimates for the global patient pool for this type of
device are about 70,000 per year. At an average $50,000 U.S. cost per
VAD, this translates into a $3.5 billion per year market. Current
treatments for heart failure are primarily medication and heart
transplantation. Medication can provide symptomatic relief for some
patients but often have side effects, and the supply of hearts for
transplants is limited to about 3,000.

The HeartSaver appears to be the technical leader in all respects, since
it is capable of being remotely powered (no wires perforating the skin),
monitored and controlled, and totally implantable in the chest cavity.
It uses a patented transcutaneous energy transfer (TET) system and a
biotelemetry data transfer system which allows the VAD to be remotely
controlled and monitored. There appears to be only two other
competitors, both of whom are already in clinical trials: Thermo
Cardiosystems and Novacor Division of Baxter Healthcare Corp. Both of
their VADs are heavier and are designed to be implanted in the abdomen,
and have either power leads and/or venting tubes which perforate the
patients' exterior protective skin tissue (consequently, they are not
totally implantable). The market cap for Thermo is currently a
staggering $1.025 Billion U.S., while the market cap for World Heart
Corp is approximately $50 million.

The major shareholders of World Heart include its CEO, Rod Bryden
(founder of SHL Systemhouse and Paperboard Industries), Michael
Cowpland, President and CEO of Corel Corp, Dr. Tofy Mussivand, the
HeartSavers principal inventor, and the Ottawa Heart Institute Research
Corporation, where the HeartSaver was developed. The Director of the
Ottawa Heart Institute is Dr. Wilbert Keon, one of the world's leading
heart surgeons.

This is not a microcap "basement operation" by any stretch. The project
has already received $18 million U.S. in government funding, with
another $4 million already approved. Sixteen R&D personnel are working
on the HeartSaver full time. Rod Bryden's two companies which he started
from scratch were worth $1.0 billion U.S. in 1991 when he stepped down
as CEO and became chairman of SC Stormont Company, a financial advisory
company. Says Bryden, "I have never seen a product with the competitive
advantage HeartSaver has. This is by far the best commercial opportunity
I've ever been presented with. Bar none."

Commencement of full clinical trials for the HeartSaver VAD is expected
in 1999, and full scale commercial production in 2001.

World Heart went public in December, 1996. I think this baby has only
one way to go - way uuupppp!
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
500we can only hope that this large number will be taken up by the funds. the tour Rick W.-2/5/2004
499Good news I hope! Better than the registration of shares to be sold....Dan Hamilton-2/5/2004
498news coming!Rick W.-2/5/2004
497Good news. Cash burn is $2.5 million CAD per month, so they certainly need moneDan Hamilton-5/23/2003
496World Heart wins over gov't for remaining $3-million 2003-05-22 16:32 ET - John E.Quinn-5/23/2003
495FDA Approves WorldHeart`s ePTFE Inflow Conduit for Use With the Novacor(R) LVAS John E.Quinn-1/14/2003
494nice gain after one day up 32%Davy Crockett-8/20/2002
493...spike bottom? Time will tell. I'm in @ 2.50 CDN Regards, PeterDavy Crockett-8/19/2002
492Let's cross our fingers and hope this is it for delays prior to human trialsDan Hamilton-4/17/2002
491February 11, 2002 08:01 FDA Approves 15 Additional Subjects for WorldHeart'Stang-2/11/2002
490Chad: Here's a quick overview. WorldHeart acquired Novacor - summer 2000. Stang-1/4/2002
489Could somebody please give me a brief update of what has happened with WHT over Chad Barrett-1/4/2002
488News: <i> WORLD HEART CORP - Novacor(R) LVAS Becomes Only Heart Assist DeStang-1/4/2002
487Well, WHT secured some more money. Looks like a good deal for the purchasers ofDan Hamilton-12/6/2001
486Better than financing, a (repayable) grant!! World Heart Corporation Receives IDan Hamilton-11/2/2001
485News coming. Financing? Toronto Stock Exchange Halt Notice: World Heart CorporDan Hamilton-11/2/2001
484eResearch Initiates Coverage On World Heart Corporation TORONTO, Oct. 4 /CNDan Hamilton-10/4/2001
483Yes, I saw that. Yeesh, $6.50 a share -- it's good they are showing some cDan Hamilton-9/21/2001
482WH is buying back 1.3 per cent of their stock!William Marsh-9/21/2001
481Conference call July 31st. I guess will find out then if there has been any resWilliam Marsh-7/25/2001
480Here is what they said: "WorldHeart is encouraged by the positive results oWilliam Marsh-7/16/2001
479Did the company tell you there was no change to the schedule?Dan Hamilton-7/15/2001
478Well, they did say there was no change in the schedule, contrary to the rumour yWilliam Marsh-7/15/2001
477No I wouldn't have expected them to comment about the calf trials. This newDan Hamilton-7/4/2001
476Strange day for World Heart. Down .80 on low volume in Canada. Up .26 on high voWilliam Marsh-7/3/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):